Towa Pharmaceutical Co., Ltd. (4553) - Financials, balance sheet (annual)

2,637 JPY

0.65%

Last update May 2, 3:24 PM JST

Market closed

Day range

2,637

2,628

2,672

Previous close

2,620

Open

2,648

Access this stock data via API

Towa Pharmaceutical Co., Ltd.

2,637.00

0.65%

Financials

Balance sheet

Fiscal date	2024	2023	2022	2021
Total assets	430.6B	371.3B	332.1B	245.7B
Current assets	217.7B	183.0B	166.9B	137.3B
Cash	—	—	—	—
Cash equivalents	—	—	—	—
Cash and cash equivalents	29.7B	24.3B	32.8B	22.9B
Other short term investments	—	—	—	—
Accounts receivable	62.9B	46.8B	42.9B	38.1B
Other receivables	—	—	—	—
Inventory	101.1B	92.9B	72.7B	61.0B
Prepaid assets	—	—	—	—
Restricted cash	—	—	—	—
Assets held for sale	—	—	—	—
Hedging assets	9.5B	4.0B	5.8B	2.9B
Other current assets	14.5B	15.0B	12.6B	12.4B
Non current assets	212.9B	188.4B	165.2B	108.4B
Properties	4.2B	3.7B	2.8B	2.1B
Land and improvements	18.3B	17.0B	16.5B	13.3B
Machinery furniture equipment	18.0B	19.0B	16.2B	12.6B
Construction in progress	55.9B	31.2B	11.7B	8.8B
Leases	—	—	—	—
Accumulated depreciation	—	—	—	—
Goodwill	83.2B	87.6B	97.1B	22.0B
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	18.0B	18.3B	19.0B	7.9B
Investments and advances	—	—	—	—
Other non current assets	1.8B	1.8B	1.9B	1.6B
Total liabilities	274.8B	234.5B	199.9B	129.1B
Current liabilities	80.1B	78.5B	115.1B	51.5B
Accounts payable	25.4B	31.3B	20.5B	14.2B
Accrued expenses	—	—	—	—
Short term debt	13.2B	11.2B	61.5B	8.3B
Deferred revenue	—	—	—	—
Tax payable	7.9B	1.2B	4.3B	2.5B
Pensions	96M	117M	108M	100M
Other current liabilities	17.5B	21.9B	17.5B	16.8B
Non current liabilities	194.6B	155.9B	84.9B	77.6B
Long term provisions	—	—	—	—
Long term debt	189.1B	150.3B	79.2B	74.1B
Provision for risks and charges	—	—	—	—
Deferred liabilities	—	—	—	—
Derivative product liabilities	—	—	—	—
Other non current liabilities	5.3B	5.3B	5.1B	2.9B
Shareholders equity
Common stock	4.7B	4.7B	4.7B	4.7B
Retained earnings	134.5B	121.2B	122.1B	108.6B
Other shareholders equity	—	—	—	—
Total shareholders equity	155.9B	136.9B	132.2B	116.6B
Additional paid in capital	7.8B	7.8B	7.8B	7.8B
Treasury stock	5.6B	5.6B	5.6B	5.6B
Minority interest	—	—	—	—